Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -16.76 | N/A |
PEG Ratio (TTM) | -0.57 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 9.36 | N/A |
P/FCF Ratio (TTM) | -1.10 | N/A |
Price to 5YR AVG Earnings Ratio | -10.58 | N/A |
Price to 5YR AVG FCF Ratio | -0.93 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -33.55% | N/A |
ROE (TTM) | -48.95% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | -40.06% | N/A |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -25.50% | 28.46% | -2.93% |
Revenue | N/A | N/A | N/A |
Net Income | -2.80% | -29.92% | -21.53% |
Cash Flow | 1.19% | -32.10% | -19.16% |
Health (7%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.40 | N/A |
Quick Ratio (TTM) | 0.17 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | 0.00 | N/A |
Shares Outstanding Growth 5YR AVG | 41.22% | N/A |